| | |
Percentage of labelled neurons
|
|---|
|
Experimental group
|
Test site
|
BK–gold
|
BK–gold + BK1 agonist
|
BK–gold + BK2 agonist
|
|
Untreated control animals
|
i.l.
|
38.8 ± 7.0
|
38.0 ± 2.4
|
0
|
| |
c.l.
|
40.4 ± 0.9
|
41.6 ± 4.6
|
1.2 ± 1.8
|
|
Immunized rats without knee injection
|
i.l.
|
42.0 ± 1.4
|
38.8 ± 2.3
|
0
|
| |
c.l.
|
41.6 ± 5.2
|
38.8 ± 6.1
|
0
|
|
Rats at 3 days of AIA
|
i.l.
|
77.0 ± 3.4
|
83.4 ± 2.9
|
0.4 ± 0.9
|
| |
c.l.
|
88.0 ± 4.7
|
88.0 ± 4.7
|
1.6 ± 2.1
|
|
Rats at 42 days of AIA
|
i.l.
|
74.8 ± 4.8
|
71.6 ± 8.9
|
0.4 ± 0.9
|
| |
c.l.
|
38.8 ± 2.3
|
38.0 ± 2.5
|
1.6 ± 3.6
|
- Values shown are the means and standard deviations. Abbreviations: i.l., ipsilateral to injected knee; c.l., contralateral to injected knee.
